The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.00 (0.00%)
Spread: 0.04 (1.053%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.80
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PHC Granted Product Registration in Brazil

13 Jul 2015 07:00

RNS Number : 7882S
Plant Health Care PLC
13 July 2015
 

13 July 2015

 

 

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Plant Health Care's Technology Granted Product Registration in Brazil

 

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that it has received its first product registration in Brazil from the Brazilian Ministry of Agriculture. With this registration, the Company and its partners will be allowed to sell products based on its current generation of commercialized protein technology for foliar use on all crops.

 

Plant Health Care's protein technology is now approved for usage in 12 countries, including Brazil and the United States, which represent the two largest agricultural markets in the world. In addition, this registration allows the Company to move forward with the development and distribution agreement it signed with Arysta LifeScience in December, 2014 for foliar application of its technology to sugarcane in Brazil. Under that contract, Arysta LifeScience agreed to evaluate the Company's current protein technology across a range of geographical locations throughout Brazil and generate detailed information on increased biomass and sucrose production. In earlier studies, the technology showed significant and reliable increases in sugarcane yield. Pending consistent and reliable test results in the evaluation program, first sales of the product in Brazil are anticipated in the 2017 crop season.

 

Paul Schmidt, CEO of Plant Health Care, commented, "This registration is very significant to Plant Health Care as Brazil is the single largest agricultural market in the world. Sugarcane is one of the country's most important crops, covering more than 20 million acres, and a feedstock for the production of ethanol, which is a major component of Brazil's renewable fuel policy. Arysta LifeScience is a strong partner for the sugarcane market and we see the potential to establish a formidable position in this important sector."

 

João Marcos Ferrari, President & CEO of Arysta LifeSciences Do Brasil, commented, "We are excited to move forward with Plant Health Care in this collaborative effort. We have seen this technology provide significant increases in yield and sugar production in sugarcane and believe it will offer substantial benefits to growers. This is another important step toward our goal to be a leader in the applications of biological products in agricultural production."

 

The Company will issue interim results for the six months to June 30, 2015 on September 14, 2015.

 

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

About Arysta LifeScience: Arysta LifeScience, now owned by Platform Specialty Products, is a leading crop protection and life science company with 2014 revenues of US$2.2 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products that meet the needs of its global partners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALXEFSXSEFF
Date   Source Headline
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.